About the Council
The Healthcare Council highlights the potential of new biotechnology solutions, the pipeline of their applications and defines the implications these new tools will have on the European regulatory and legislative framework.
New advances in biological sciences combined with the acceleration of computing, data processing and artificial intelligence are transforming how healthcare is delivered to patients.
The Healthcare Council develops proposals in areas significantly impacted by this new wave of innovation: cell and gene therapies, medicines for rare diseases and children, data and digital, regulatory efficiencies, biosimilars and procurement.
The Council also delivers the Patient Bio-Forum as the platform of exchange of views between patient organisations and healthcare biotechnology members.
The Council works through three Council meetings per year, supported by Working Groups across priority topics.
PUBLICATIONS
View all
UPCOMING EVENTS
View all
SMEs in a Changing World: The Impact of the Revision of the Pharmaceutical Legislation on Europe’s innovative SMEs
11 October @ 1:30 pm - 3:00 pm CEST